{"TopicDetails": {"type": 0, "ccm2Id": 31053543, "cftId": 0, "identifier": "PHC-08-2014", "title": "Vaccine development for poverty-related and neglected infectious diseases: tuberculosis", "publicationDateLong": 1386720000000, "callIdentifier": "H2020-PHC-2014-2015", "callTitle": "Personalising health and care", "callccm2Id": 31054065, "allowPartnerSearch": true, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020 Framework Programme"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}], "topicMGAs": [], "tags": ["NID", "Poverty related diseases", "Adjuvant", "PRD", "Clinical trials", "Tuberculosis", "Booster", "Antigen", "Live vaccine", "Pre-exposure", "Prevention", "Post-exposure", "XDR", "Vaccine", "Acid-fast bacilli", "Drug-resistant", "TB control", "TB", "Neglected infectious disease", "MDR"], "keywords": ["Vaccines", "Immunology", "Global health", "Infectious diseases", "Bacteria"], "flags": ["IntlCoop", "Gender"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "RIA Research and Innovation action", "typeOfMGA": []}], "plannedOpeningDate": "11 December 2013", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["15 April 2014"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3205935": [{"action": "PHC-09-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "single-stage", "deadlineDates": ["24 February 2015"], "budgetYearMap": {"0": 88000000}, "budgetTopicActionMap": {}}, {"action": "PHC-15-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "single-stage", "deadlineDates": ["24 February 2015"], "budgetYearMap": {"0": 88000000}, "budgetTopicActionMap": {}}, {"action": "PHC-33-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "single-stage", "deadlineDates": ["24 February 2015"], "budgetYearMap": {"0": 88000000}, "budgetTopicActionMap": {}}], "3205936": [{"action": "PHC-24-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "two-stage", "deadlineDates": ["14 October 2014", "21 April 2015"], "budgetYearMap": {"0": 306000000}, "budgetTopicActionMap": {}}, {"action": "PHC-11-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "two-stage", "deadlineDates": ["14 October 2014", "21 April 2015"], "budgetYearMap": {"0": 306000000}, "budgetTopicActionMap": {}}, {"action": "PHC-18-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "two-stage", "deadlineDates": ["14 October 2014", "21 April 2015"], "budgetYearMap": {"0": 306000000}, "budgetTopicActionMap": {}}, {"action": "PHC-16-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "two-stage", "deadlineDates": ["14 October 2014", "21 April 2015"], "budgetYearMap": {"0": 306000000}, "budgetTopicActionMap": {}}, {"action": "PHC-14-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "two-stage", "deadlineDates": ["14 October 2014", "21 April 2015"], "budgetYearMap": {"0": 306000000}, "budgetTopicActionMap": {}}, {"action": "PHC-03-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "two-stage", "deadlineDates": ["14 October 2014", "21 April 2015"], "budgetYearMap": {"0": 306000000}, "budgetTopicActionMap": {}}, {"action": "PHC-04-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "two-stage", "deadlineDates": ["14 October 2014", "21 April 2015"], "budgetYearMap": {"0": 306000000}, "budgetTopicActionMap": {}}, {"action": "PHC-02-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "two-stage", "deadlineDates": ["14 October 2014", "21 April 2015"], "budgetYearMap": {"0": 306000000}, "budgetTopicActionMap": {}}, {"action": "PHC-22-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "two-stage", "deadlineDates": ["14 October 2014", "21 April 2015"], "budgetYearMap": {"0": 306000000}, "budgetTopicActionMap": {}}], "3205937": [{"action": "PHC-25-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "single-stage", "deadlineDates": ["21 April 2015"], "budgetYearMap": {"0": 104500000}, "budgetTopicActionMap": {}}, {"action": "PHC-27-2015 - COFUND-PCP COFUND (PCP)", "plannedOpeningDate": "30 July 2014", "deadlineModel": "single-stage", "deadlineDates": ["21 April 2015"], "budgetYearMap": {"0": 104500000}, "budgetTopicActionMap": {}}, {"action": "PHC-28-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "single-stage", "deadlineDates": ["21 April 2015"], "budgetYearMap": {"0": 104500000}, "budgetTopicActionMap": {}}, {"action": "PHC-29-2015 - COFUND-PPI COFUND (PPI)", "plannedOpeningDate": "30 July 2014", "deadlineModel": "single-stage", "deadlineDates": ["21 April 2015"], "budgetYearMap": {"0": 104500000}, "budgetTopicActionMap": {}}, {"action": "PHC-30-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "single-stage", "deadlineDates": ["21 April 2015"], "budgetYearMap": {"0": 104500000}, "budgetTopicActionMap": {}}, {"action": "PHC-21-2015 - RIA Research and Innovation action", "plannedOpeningDate": "30 July 2014", "deadlineModel": "single-stage", "deadlineDates": ["21 April 2015"], "budgetYearMap": {"0": 104500000}, "budgetTopicActionMap": {}}], "3205938": [{"action": "PHC-17-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "two-stage", "deadlineDates": ["11 March 2014", "19 August 2014"], "budgetYearMap": {"0": 303000000}, "budgetTopicActionMap": {}}, {"action": "PHC-10-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "two-stage", "deadlineDates": ["11 March 2014", "19 August 2014"], "budgetYearMap": {"0": 303000000}, "budgetTopicActionMap": {}}, {"action": "PHC-05-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "two-stage", "deadlineDates": ["11 March 2014", "19 August 2014"], "budgetYearMap": {"0": 303000000}, "budgetTopicActionMap": {}}, {"action": "PHC-06-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "two-stage", "deadlineDates": ["11 March 2014", "19 August 2014"], "budgetYearMap": {"0": 303000000}, "budgetTopicActionMap": {}}, {"action": "PHC-32-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "two-stage", "deadlineDates": ["11 March 2014", "19 August 2014"], "budgetYearMap": {"0": 303000000}, "budgetTopicActionMap": {}}, {"action": "PHC-23-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "two-stage", "deadlineDates": ["11 March 2014", "19 August 2014"], "budgetYearMap": {"0": 303000000}, "budgetTopicActionMap": {}}, {"action": "PHC-01-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "two-stage", "deadlineDates": ["11 March 2014", "19 August 2014"], "budgetYearMap": {"0": 303000000}, "budgetTopicActionMap": {}}, {"action": "PHC-13-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "two-stage", "deadlineDates": ["11 March 2014", "19 August 2014"], "budgetYearMap": {"0": 303000000}, "budgetTopicActionMap": {}}], "3205939": [{"action": "PHC-19-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "single-stage", "deadlineDates": ["15 April 2014"], "budgetYearMap": {"0": 87000000}, "budgetTopicActionMap": {}}, {"action": "PHC-20-2014 - IA Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "single-stage", "deadlineDates": ["15 April 2014"], "budgetYearMap": {"0": 87000000}, "budgetTopicActionMap": {}}, {"action": "PHC-26-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "single-stage", "deadlineDates": ["15 April 2014"], "budgetYearMap": {"0": 87000000}, "budgetTopicActionMap": {}}, {"action": "PHC-34-2014 - CSA Coordination and support action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "single-stage", "deadlineDates": ["15 April 2014"], "budgetYearMap": {"0": 87000000}, "budgetTopicActionMap": {}}], "3205941": [{"action": "PHC-08-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "single-stage", "deadlineDates": ["15 April 2014"], "budgetYearMap": {"0": 98200000}, "budgetTopicActionMap": {}}, {"action": "PHC-31-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "single-stage", "deadlineDates": ["15 April 2014"], "budgetYearMap": {"0": 98200000}, "budgetTopicActionMap": {}}, {"action": "PHC-15-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "single-stage", "deadlineDates": ["15 April 2014"], "budgetYearMap": {"0": 98200000}, "budgetTopicActionMap": {}}, {"action": "PHC-07-2014 - RIA Research and Innovation action", "plannedOpeningDate": "11 December 2013", "deadlineModel": "single-stage", "deadlineDates": ["15 April 2014"], "budgetYearMap": {"0": 98200000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["0"]}, "description": "<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p><u>Specific challenge:</u> Vaccines offer a safe and cost-effective way to protect large populations against infectious diseases, or at least to mitigate the clinical course of these diseases. Yet many poverty-related and neglected infectious diseases continue to escape attempts to develop effective vaccines against them. </p><p>Disappointing results of recent clinical trials point to bottlenecks in identifying viable candidate vaccines, which if unaddressed will continue to present significant risks of failure at relatively late stages of the development process. </p><p>The specific challenge will be to shift this \u2018risk curve\u2019 in order better to select successful vaccine candidates (and discard those with a higher risk of failure) at an earlier stage of the vaccine development process. </p><p><u>Scope:</u> Proposals should focus on strengthening the capacity for discovery and early development of new vaccine candidates for tuberculosis by addressing all of the following inter-related elements: </p><p>1. Establishment of a platform for the identification of several new diverse and novel vaccine candidates for tuberculosis, and their pre-clinical and early clinical testing. </p><p>2. The major bottlenecks in vaccine development should be addressed; in particular better ways for early distinction between successful candidates and those that will eventually fail in late stage clinical trials. Proposals should therefore address areas such as <i>in vitro</i> and <i>in silico</i> testing, predictive animal models, predictive correlates of protection, phase 0 trials, first in man trials and innovative risk prediction methods, taking into account potential sex-specific differences. Based on specific gating and priority setting criteria the most promising new vaccine candidates for tuberculosis should be compared with other candidates and selected in an objective and transparent process according to their merits in line with effective vaccine portfolio management.</p><p>3. The successful proposal shall be part of the Global TB Vaccine Partnership and continue its vaccine development in the context of this initiative in collaboration with the European and Developing Countries Clinical Trials Partnership (EDCTP), and a pathway and commitment towards this must form an integral part of the proposal.</p><p>In line with the Union\u2019s strategy on international cooperation<sup><sup>[1]</sup></sup> in research and innovation, international cooperation is encouraged. The proposals should also address the barriers and possible facilitators regarding the uptake and implementation of a new vaccine in low, middle and high income countries in different regions of the world.</p><p>The Commission considers that proposals requesting a contribution from the EU of between EUR 15 and 25 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.</p><p><u>Expected impact:</u> This should provide:</p><ul>  <li>Reduction in the cost associated with late stage vaccine failure, increasing the number of other candidates which can be tested with the same resources, thus increasing the chance of discovery of an effective vaccine</li>  <li>Contribution to the implementation of\u00a0 the Global TB Vaccine Partnership for the development of tuberculosis vaccines and, (currently under development in collaboration with European Investment Bank and Bill and Melinda Gates Foundation) including the establishment of close links with the European and Developing Countries Clinical Trials Partnership (EDCTP).</li> </ul><p><u>Type of action:</u>Research and innovation actions</p><p>[1] COM(2012)497</p>\n<SPAN class=\"topicdescriptionkind\">Cross-cutting Priorities</SPAN>:<p><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=31045243;crossCuttingPriorityCode=IntlCoop;sortQuery=sortStatus;orderBy=asc\">International cooperation</a><br><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=31045243;crossCuttingPriorityCode=Gender;sortQuery=sortStatus;orderBy=asc\">Gender</a><br></p>\n", "conditions": "<p>Please read carefully all provisions below before the preparation of your application.</p>\r\n<ol>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">List of countries and applicable rules for funding: </span></strong>described in <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/annexes/h2020-wp1415-annex-a-countries-rules_en.pdf\">part A of the General Annexes</a> of the General Work Programme.<br />\r\n    &nbsp;<br />\r\n    In recognition of the opening of the US National Institutes of Health&rsquo;s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding to support its participation in projects supported under all topics in calls under the Societal Challenge &lsquo;Health, demographic change and well-being&rsquo;.&nbsp;<br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Eligibility and admissibility conditions:</span></strong> described in <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/annexes/h2020-wp1415-annex-b-adm_en.pdf\">part B</a> and <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/annexes/h2020-wp1415-annex-c-elig_en.pdf\">C of the General Annexes</a> of the General Work Programme<span style=\"color: rgb(51,153,102)\">&nbsp;</span><br />\r\n    <br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Evaluation </span></strong><br />\r\n    <br />\r\n    <strong><span style=\"color: rgb(0,51,102)\">3.1&nbsp; Evaluation criteria and procedure, scoring and threshold:</span></strong> described in <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/annexes/h2020-wp1415-annex-h-esacrit_en.pdf\">part H of the General Annexes</a> of the General Work Programme, with the following exceptions:<br />\r\n    -The thresholds for each criterion in a single stage process will be 4, 4 and 3. The cumulative threshold will be 12. <br />\r\n    - If a proposal fails to achieve the threshold for a criterion at any stage, the evaluation of the proposal will be stopped. <br />\r\n    - For the evaluation of topics PHC7 &ndash; 2014 and PHC8 &ndash; 2014, the Commission will organise hearings at stage 1 with applicants as part of the panel deliberations for all proposals above threshold.<br />\r\n    <span style=\"color: rgb(51,153,102)\">&nbsp;</span><br />\r\n    <br />\r\n    <strong><span style=\"color: rgb(0,51,102)\">3.2</span></strong> <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/pse/h2020-guide-pse_en.pdf\">Guide to the submission and evaluation process</a><br />\r\n    <br />\r\n    <br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Proposal page limits and layout: </span></strong>Please refer to Part B of the standard proposal template.<br />\r\n    &nbsp;</li>\r\n    <li><span style=\"color: rgb(0,51,102)\"><strong>Indicative timetable for evaluation and grant agreement:</strong></span><br />\r\n    Information on the outcome of <strong>one-stage </strong>evaluation: maximum 5 months from the final date for submission.<br />\r\n    Signature of grant agreements: maximum 3 months from the date of informing successful applicants.<br />\r\n    <br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic: </span></strong><br />\r\n    <br />\r\n    <u>Research and Innovation Action:</u><br />\r\n    <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/annexes/h2020-wp1415-annex-d-ria_en.pdf\">Specific provisions and funding rates</a> <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/call_ptef/pt/h2020-call-pt-ria-ia_en.pdf\">Standard proposal template (administrative forms and structure of technical annex</a>)<br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/amga/h2020-amga_en.pdf\">Annotated Model Grant Agreement</a><br />\r\n    <br />\r\n    For information,&nbsp;a pdf. template of the evaluation form for this&nbsp;topic is available on the call page under <a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/h2020-phc-2014-single-stage.html#tab2\">call&nbsp;documents</a>. In addition, to be consulted on the same page a specific template for essential information for clinical trials/studies/investigations is available.&nbsp;<br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Additional provisions:</span></strong><br />\r\n    <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/annexes/h2020-wp1415-annex-i-budgflex_en.pdf\">Horizon 2020 budget flexibility </a><br />\r\n    <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/annexes/h2020-wp1415-annex-j-classinfo_en.pdf\">Classified information</a><br />\r\n    <br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Open access must be granted to all scientific publications resulting from Horizon 2020 actions, and proposals must refer to measures envisaged.</span></strong> Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.</li>\r\n</ol>\r\n<p>&nbsp;</p>", "supportInfo": "<div>\r\n<p><strong><span><a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/support/national_contact_points.html\">National Contact Points (NCP)</a></span></strong><span> &ndash; contact your NCP for further assistance.</span></p>\r\n<p><strong><span><a href=\"http://www.fitforhealth.eu\">Fit for Health</a></span></strong><span> : Developed by the Fit for Health network in close cooperation with the Health-NCPs. The quality checked database contains expertise profiles of researchers and SMEs acting in the Health / Life sciences sector. The service includes partner search activities advice on all aspects related to a research project, starting with help in first orientation and strategy development to proposal preparation, implementation, exploitation and promotion</span></p>\r\n<p><a href=\"http://een.ec.europa.eu/\"><strong>Enterprise Europe Network</strong></a> &ndash; contact your EEN national contact point for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.</p>\r\n<p><a href=\"http://www.b2match.eu/ict2013/\"><strong>B2Match networking</strong> </a>platform with project ideas and participant profiles following the networking event in ICT 2013 in Vilnius</p>\r\n<p><strong><a href=\"http://www.ideal-ist.eu/\">Ideal-IST</a></strong> partner search facility</p>\r\n<p><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\"><strong>Research Enquiry Service</strong></a> &ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</p>\r\n<p><a href=\"http://ec.europa.eu/research/participants/api/contact/index.html\"><strong>IT Helpdesk</strong></a> &ndash; contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.</p>\r\n<p><strong>Ethics</strong> &ndash; to ensure compliance with ethical issues, further information is available on the <a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\">Participant Portal</a>&nbsp;and on the <a href=\"http://ec.europa.eu/research/science-society/index.cfm?fuseaction=public.topic&amp;id=1289&amp;lang=1\">Science and Society Portal</a>.</p>\r\n<p><a href=\"http://www.iprhelpdesk.eu/\"><strong>European IPR Helpdesk</strong></a> assists you on intellectual property issues.</p>\r\n<p><a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\"><strong>The European Charter for Researchers and the Code of Conduct for their recruitment</strong></a></p>\r\n<p><a href=\"http://www.cen.eu/cen/Services/Innovation/Pages/default.aspx\"><strong>CEN</strong></a> and <a href=\"http://www.cenelec.eu/aboutcenelec/whatwestandfor/fosterinnovation/randd.html\"><strong>CENELEC</strong></a>, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at <a href=\"mailto:research@cencenelec.eu\">research@cencenelec.eu</a>.</p>\r\n<p><strong><a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/grants/applying-for-funding/find-partners_en.htm\">Partner Search Services</a></strong> helps you find a partner organisation for your proposal.</p>\r\n<p><a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/funding/guide.html\"><strong>H2020 Funding Guide</strong></a> your online guide on the procedures from proposal submission to managing your grant.</p>\r\n</div>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>To access the Electronic Submission Service of the topic, please select the <strong>type of action</strong> that is most relevant to your proposal from the list below and click on the <strong>'Start Submission'</strong> button. You will then be asked to confirm your choice of the type of action, the topic for the call, as these cannot be changed subsequently in the submission system. Upon confirmation you will be linked to the correct entry point.</p>\n<p>To access existing draft proposals for this topic, please login to the Participant Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [{"callId": 4412, "id": 283074, "title": "FAQ", "sectionId": 4412, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 333660, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/phc-08-2014/1612606-1612602-2014_06_24_1447_sc1_h2020_faq_en.pdf", "id": 1612606, "fileName": "1612602-2014_06_24_1447_sc1_h2020_faq_en.pdf", "common": false, "crc32": 1399575871}]}, {"callId": 4412, "id": 283067, "title": "Evaluation form for H2020-PHC-2014-single-stage-topic 31 - RIA ", "sectionId": 4412, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 291933, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/phc-08-2014/1592637-h2020-call-ef-ria-ia-csa_en.pdf", "id": 1592637, "fileName": "h2020-call-ef-ria-ia-csa_en.pdf", "common": false, "crc32": 1254759458}]}, {"callId": 4412, "id": 283071, "title": "Evaluation form for H2020-PHC-2014-single-stage-topics 7-8-15-19-26 RIA", "sectionId": 4412, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 21224, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/phc-08-2014/1592633-self-evaluation_form_single_stage_sc1-phc-ria-2014_thresholds4-4-3_en.pdf", "id": 1592633, "fileName": "Self-evaluation form single stage SC1-PHC-RIA-2014 thresholds4-4-3_en.pdf", "common": false, "crc32": 523176342}]}, {"callId": 4412, "id": 283068, "title": "Evaluation form for H2020-PHC-2014-single-stage CSA", "sectionId": 4412, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 28004, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/phc-08-2014/1592624-evaluation_form_phc-34-2014_csa_en.pdf", "id": 1592624, "fileName": "evaluation_form_PHC-34-2014_CSA_en.pdf", "common": false, "crc32": 1619776034}]}, {"callId": 4412, "id": 283069, "title": "Essential information for clinical trials/studies/investigations", "sectionId": 4412, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 154929, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/phc-08-2014/1600139-essential_information_for_clinical_studies_en.pdf", "id": 1600139, "fileName": "Essential information for clinical studies_EN.pdf", "common": false, "crc32": 1494236432}]}, {"callId": 4412, "id": 283072, "title": "Commission Decision_clinical study reimbursement based on unit costs", "sectionId": 4412, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 113661, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/phc-08-2014/1602602-commission_decision_clinical_study_reimbursement_based_on_unit_costs_en.pdf", "id": 1602602, "fileName": "Commission Decision_clinical study reimbursement based on unit costs_EN.pdf", "common": false, "crc32": 3359071063}]}, {"callId": 4412, "id": 283070, "title": "A guide to ICT-related activities in WP2014-15", "sectionId": 4412, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 1097621, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/phc-08-2014/1587744-guide-to-ict-related-activities-in-wp2014-15_en.pdf", "id": 1587744, "fileName": "Guide-to-ICT-related-activities-in-WP2014-15_en.pdf", "common": false, "crc32": 121062459}]}], "infoPackDossiers": [{"callId": 4411, "id": 272208, "title": "Legal basis - Framework Programme H2020", "sectionId": 4411, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 1607893, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/common/1595116-h2020-eu-establact-oj_en.pdf", "id": 1595116, "fileName": "h2020-eu-establact-oj_en.pdf", "common": true, "crc32": 2063613640}]}, {"callId": 4411, "id": 272210, "title": "Legal basis - Specific Programme H2020", "sectionId": 4411, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 1360406, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/common/1595115-h2020-sp-oj_en.pdf", "id": 1595115, "fileName": "h2020-sp-oj_en.pdf", "common": true, "crc32": 4123327472}]}, {"callId": 4411, "id": 272211, "title": "WP H2020 - 1. Introduction", "sectionId": 4411, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 517130, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/common/1617601-part_1_introduction_v2.0_en.pdf", "id": 1617601, "fileName": "Part 1_Introduction_v2.0_EN.pdf", "common": true, "crc32": 1406880430}]}, {"callId": 4411, "id": 272221, "title": "WP H2020 - 8. Health, demographic change and wellbeing", "sectionId": 4411, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 1182216, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/common/1652619-08._consolid__upd_apr_2015_sc1_health_en.pdf", "id": 1652619, "fileName": "08. Consolid_ upd Apr 2015_SC1_Health_en.pdf", "common": true, "crc32": 1524507016}]}, {"callId": 4411, "id": 272259, "title": "WP H2020 - 19. General Annexes ", "sectionId": 4411, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 881149, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/common/1617621-part_19_general_annexes_v.2.0_en.pdf", "id": 1617621, "fileName": "Part 19_General annexes_v.2.0_EN.pdf", "common": true, "crc32": 1466930081}]}], "callDetailsJSONItem": {"additionalInfo": "<p><strong>\ufeff</strong></p>\r\n<p>Topic&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Prop. Received&nbsp;&nbsp;&nbsp;&nbsp;Invited to stage 2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indicative Budget (EUR million)<br />\r\nPHC-01-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;358&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 172&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;54<br />\r\nPHC-05-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 121&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24<br />\r\nPHC-06-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15<br />\r\nPHC-10-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;462&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;138&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 48<br />\r\nPHC-13-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 296&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;128&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60<br />\r\nPHC-17-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 136&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 48<br />\r\nPHC-23-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 107&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30<br />\r\nPHC-32-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 116&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24<br />\r\n<strong>Total&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1681&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;626&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;303</strong></p>\r\n<p>&nbsp;</p>\r\n<p>Topic &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Prop. Received &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Invited to stage 2 &nbsp; &nbsp; &nbsp; &nbsp; Indicative Budget (EUR million)<br />\r\nPHC-02-2015 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 205 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 44 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;36<br />\r\nPHC-03-2015 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 355 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 108 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;30<br />\r\nPHC-04-2015 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 78 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 13 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;18<br />\r\nPHC-11-2015 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 348 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 97 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;49<br />\r\nPHC-14-2015 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 421 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 130 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;62<br />\r\nPHC-16-2015 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 312 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 33 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;36<br />\r\nPHC-18-2015 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 134 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 36 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;28<br />\r\nPHC-22-2015 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 184 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 34 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;17<br />\r\nPHC-24-2015 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 59 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 11 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;30<br />\r\n<strong>Grand Total &nbsp; &nbsp; &nbsp; &nbsp;2096 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 506 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;306</strong></p>\r\n<p>&nbsp;</p>", "latestInfos": [{"approvalDate": "Nov 6, 2015 2:15:04 PM", "lastChangeDate": "Nov 6, 2015 2:14:34 PM", "content": "<p>After the changes to the PP call pages layout, the flash info is available in the section of topic conditions and documents.</p>"}, {"approvalDate": "Sep 4, 2015 5:28:39 PM", "lastChangeDate": "Sep 4, 2015 5:27:19 PM", "content": "<p>An&nbsp;update of the evaluation results (Flash Call Info) is available as of today (4th September 2015)&nbsp; under the tab <a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/h2020-phc-2015-single-stage.html#tab2\">'Call documents'</a>.</p>\r\n<p>&nbsp;</p>"}, {"approvalDate": "Aug 15, 2015 8:50:00 PM", "lastChangeDate": "Aug 15, 2015 8:33:52 PM", "content": "<p>An overview of the evaluation results (Flash Call Info) is now available here or under the tab <a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/h2020-phc-2015-single-stage.html#tab2\">'Call documents'</a>.</p>\r\n<p>&nbsp;</p>"}, {"approvalDate": "Jul 27, 2015 2:40:24 PM", "lastChangeDate": "Jul 27, 2015 2:40:10 PM", "content": "<p>We expect to send out letters informing the applicants about the outcome of stage two evaluation around end of August.</p>"}, {"approvalDate": "Jul 27, 2015 2:38:28 PM", "lastChangeDate": "Jul 27, 2015 2:38:14 PM", "content": "<p>We expect to send out letters informing the applicants about the outcome of stage two evaluation around end of August.</p>\r\n<p>The submission session is now available for: PHC-02-2015(RIA), PHC-03-2015(RIA), PHC-04-2015(RIA), PHC-11-2015(RIA), PHC-14-2015(RIA), PHC-16-2015(RIA), PHC-18-2015(RIA), PHC-22-2015(RIA), PHC-24-2015(RIA)</p>"}, {"approvalDate": "Jun 12, 2015 11:31:48 AM", "lastChangeDate": "Jun 12, 2015 11:30:54 AM", "content": "<p>An overview of the evaluation results (flash call info) is now available under the tab 'Call documents'.</p>"}, {"approvalDate": "Apr 22, 2015 3:16:20 PM", "lastChangeDate": "Apr 22, 2015 3:15:53 PM", "content": "<p>A total of 631 proposals were submitted in response to this call. The breakdown per topic is as follows:<br />\r\nPHC-21-2015: 165 proposals<br />\r\nPHC-25-2015: 174 <br />\r\nPHC-27-2015: 5 <br />\r\nPHC-28-2015: 184 <br />\r\nPHC-29-2015: 3 <br />\r\nPHC-30-2015: 100</p>\r\n<p>&nbsp;</p>"}, {"approvalDate": "Mar 3, 2015 12:59:23 PM", "lastChangeDate": "Mar 3, 2015 12:58:44 PM", "content": "<p>A total of 80 proposals were submitted in response to this call. <br />\r\nThe number of proposals for each topic is shown below.<br />\r\nPHC-09 : 6<br />\r\nPHC-15 : 46<br />\r\nPHC-33 : 28</p>"}, {"approvalDate": "Nov 28, 2014 11:03:13 AM", "lastChangeDate": "Nov 28, 2014 11:02:35 AM", "content": "<p>After the update to the Horizon 2020 Work Programme of 22 July 2014, topics<br />\r\n<strong>PHC-09-2015 - </strong>Vaccine development for poverty-related and neglected infectious diseases: HIV/AIDS and<br />\r\n<strong>PHC-15-2015 </strong>- Clinical research on regenerative medicine <br />\r\nare not included within this specific call but have been moved to call <strong><a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/calls/h2020-phc-2015-single-stage_rtd.html\">H2020-PHC-2015-single-stage_RTD</a></strong>.</p>\r\n<p>&nbsp;</p>"}, {"approvalDate": "Nov 20, 2014 4:15:12 PM", "lastChangeDate": "Nov 20, 2014 4:15:05 PM", "content": "<p>The submission session is now available for: PHC-01-2014(RIA), PHC-05-2014(RIA), PHC-06-2014(RIA), PHC-10-2014(RIA), PHC-13-2014(RIA), PHC-17-2014(RIA), PHC-23-2014(RIA), PHC-32-2014(RIA)</p>\r\n<p>Stage 2</p>\r\n<p>Topic&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prop. Received</p>\r\n<p>PHC-01-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 168<br />\r\nPHC-05-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37<br />\r\nPHC-06-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;30<br />\r\nPHC-10-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 132<br />\r\nPHC-13-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 121<br />\r\nPHC-17-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;53<br />\r\nPHC-23-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;33<br />\r\nPHC-32-2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;31<br />\r\n<strong>Grand Total&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;605</strong></p>"}, {"approvalDate": "Sep 5, 2014 11:04:58 AM", "lastChangeDate": "Sep 5, 2014 11:04:58 AM", "content": "The submission session is now available for: PHC-21-2015(RIA), PHC-25-2015(RIA), PHC-27-2015(COFUND-PCP), PHC-28-2015(RIA), PHC-29-2015(COFUND-PPI), PHC-30-2015(RIA)"}, {"approvalDate": "Jul 23, 2014 4:25:49 PM", "lastChangeDate": "Sep 5, 2014 11:04:58 AM", "content": "<p>After the update to the Horizon 2020 Work Programme of 22 July 2014, topics<br />\r\n<strong>PHC-09-2015 - </strong>Vaccine development for poverty-related and neglected infectious diseases: HIV/AIDS and<br />\r\n<strong>PHC-15-2015 </strong>- Clinical research on regenerative medicine <br />\r\nhave been moved to call <strong>H2020-PHC-2015-single-stage_RTD</strong>.</p>"}, {"approvalDate": "Aug 4, 2014 2:19:36 PM", "lastChangeDate": "Aug 4, 2014 2:19:15 PM", "content": "<p>The submission session is now available for: PHC-02-2015(RIA), PHC-03-2015(RIA), PHC-04-2015(RIA), PHC-11-2015(RIA), PHC-14-2015(RIA), PHC-16-2015(RIA), PHC-18-2015(RIA), PHC-22-2015(RIA), PHC-24-2015(RIA)</p>"}, {"approvalDate": "Jul 30, 2014 5:13:32 PM", "lastChangeDate": "Jul 30, 2014 5:13:32 PM", "content": "The submission session is now available for: PHC-02-2015(RIA), PHC-03-2015(RIA), PHC-04-2015(RIA), PHC-11-2015(RIA), PHC-14-2015(RIA), PHC-16-2015(RIA), PHC-18-2015(RIA), PHC-22-2015(RIA), PHC-24-2015(RIA), PHC-33-2015(RIA)"}, {"approvalDate": "Jul 24, 2014 5:45:36 PM", "lastChangeDate": "Jul 30, 2014 5:13:32 PM", "content": "<p><strong><span>After the update to the Horizon 2020 Work Programme of 22 July 2014:<br />\r\n&minus; Topic PHC 14: clarification. </span><span style=\"color: #ff0000\"><br />\r\n&minus; Topic PHC 33: <strong>has been moved to call H2020-PHC-2015-single-stage_RTD.</strong><br />\r\n</span></strong><strong><span>&minus; Conditions for PHC-call: dates of opening and deadlines + modifications in call conditions.</span></strong></p>"}, {"approvalDate": "Jul 30, 2014 5:11:24 PM", "lastChangeDate": "Jul 30, 2014 5:11:24 PM", "content": "The submission session is now available for: PHC-09-2015(RIA), PHC-15-2015(RIA), PHC-33-2015(RIA)"}, {"approvalDate": "Jul 24, 2014 5:46:18 PM", "lastChangeDate": "Jul 30, 2014 5:11:24 PM", "content": "<p>&nbsp;</p>\r\n<p>After the update to the Horizon 2020 Work Programme of 22 July 2014:<br />\r\n&minus; Topic PHC 9: clarification. <br />\r\n&minus; Topic PHC 33: clarification + switch from 2-stage to single stage call with hearings.<br />\r\n&minus; Conditions for PHC-call: dates of opening and deadlines + modifications in call conditions. <br />\r\n&nbsp;</p>"}, {"approvalDate": "Oct 13, 2014 11:37:17 AM", "lastChangeDate": "Jul 24, 2014 4:41:14 PM", "content": "<p>After the update to the Horizon 2020 Work Programme of 22 July 2014, topics<br />\r\n<strong>PHC-09-2015 - </strong>Vaccine development for poverty-related and neglected infectious diseases: HIV/AIDS and<br />\r\n<strong>PHC-15-2015 </strong>- Clinical research on regenerative medicine <br />\r\nhave been moved to call <strong>H2020-PHC-2015-single-stage_RTD</strong>.</p>\r\n<p>&nbsp;</p>"}, {"approvalDate": "Jul 24, 2014 3:01:11 PM", "lastChangeDate": "Jul 23, 2014 4:29:41 PM", "content": "<p>After the update to the Horizon 2020 Work Programme of 22 July 2014:<br />\r\n&minus; Topic PHC 14: clarification. <br />\r\n&minus; Topic PHC 33: <strong>has been moved to call H2020-PHC-2015-single-stage_RTD.</strong><br />\r\n&minus; Conditions for PHC-call: dates of opening and deadlines + modifications in call conditions.</p>"}, {"approvalDate": "May 26, 2014 3:49:12 PM", "lastChangeDate": "May 26, 2014 3:49:03 PM", "content": "<p>The submission session is now available for: PHC-01-2014(RIA), PHC-05-2014(RIA), PHC-06-2014(RIA), PHC-10-2014(RIA), PHC-13-2014(RIA), PHC-17-2014(RIA), PHC-23-2014(RIA), PHC-32-2014(RIA)</p>"}, {"approvalDate": "May 13, 2014 12:20:03 PM", "lastChangeDate": "May 13, 2014 12:19:15 PM", "content": "<p>A total of 451 proposals were submitted in response to this call. The number of proposals for each topic is shown below:<br />\r\nPHC-07-2014 : 11<br />\r\nPHC-08-2014 : 5<br />\r\nPHC-15-2014 : 30<br />\r\nPHC-19-2014 : 79<br />\r\nPHC-20-2014 : 56<br />\r\nPHC-26-2014 : 254<br />\r\nPHC-31-2014 : 9<br />\r\nPHC-34-2014&nbsp;: 7&nbsp;</p>"}, {"approvalDate": "Jan 28, 2014 12:30:01 PM", "lastChangeDate": "Jan 28, 2014 12:30:01 PM", "content": "The submission session is now available for: PHC-07-2014(RIA), PHC-08-2014(RIA), PHC-15-2014(RIA), PHC-19-2014(RIA), PHC-20-2014(IA), PHC-26-2014(RIA), PHC-31-2014(RIA), PHC-34-2014(CSA)"}, {"approvalDate": "Dec 20, 2013 4:39:13 PM", "lastChangeDate": "Dec 20, 2013 4:39:13 PM", "content": "The submission session is now available for: PHC-01-2014(RIA), PHC-05-2014(RIA), PHC-06-2014(RIA), PHC-10-2014(RIA), PHC-13-2014(RIA), PHC-17-2014(RIA), PHC-23-2014(RIA), PHC-32-2014(RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}